

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.44872658 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.39309288 |
| 3 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.96265896 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.55485912 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.55485912 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.54088621 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.54088621 |
| 8 | response to type I interferon (GO:0034340) | 4.48929853 |
| 9 | cellular response to type I interferon (GO:0071357) | 4.48078160 |
| 10 | type I interferon signaling pathway (GO:0060337) | 4.48078160 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.40534319 |
| 12 | heme biosynthetic process (GO:0006783) | 4.32971147 |
| 13 | response to interferon-beta (GO:0035456) | 4.30653351 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.22343119 |
| 15 | response to interferon-alpha (GO:0035455) | 4.14437694 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.11071993 |
| 17 | heme metabolic process (GO:0042168) | 4.01729561 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 4.00998147 |
| 19 | negative regulation of viral genome replication (GO:0045071) | 3.93985637 |
| 20 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.90815337 |
| 21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.86057228 |
| 22 | T cell migration (GO:0072678) | 3.78789142 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 3.76027282 |
| 24 | detection of bacterium (GO:0016045) | 3.73910736 |
| 25 | detection of other organism (GO:0098543) | 3.64012796 |
| 26 | porphyrin-containing compound metabolic process (GO:0006778) | 3.62404150 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 3.61316548 |
| 28 | negative T cell selection (GO:0043383) | 3.55855747 |
| 29 | regulation of RIG-I signaling pathway (GO:0039535) | 3.53991893 |
| 30 | cellular response to interferon-beta (GO:0035458) | 3.53783183 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.53686868 |
| 32 | cytidine metabolic process (GO:0046087) | 3.52747091 |
| 33 | cytidine catabolic process (GO:0006216) | 3.52747091 |
| 34 | cytidine deamination (GO:0009972) | 3.52747091 |
| 35 | tetrapyrrole biosynthetic process (GO:0033014) | 3.51227310 |
| 36 | negative thymic T cell selection (GO:0045060) | 3.51006790 |
| 37 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.50610885 |
| 38 | regulation of T cell tolerance induction (GO:0002664) | 3.50047772 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.43931530 |
| 40 | defense response to protozoan (GO:0042832) | 3.39038105 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 3.38915024 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.38292634 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 3.38292634 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.38292634 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.38292634 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.38292634 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.38292634 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 3.35395739 |
| 49 | T-helper 1 type immune response (GO:0042088) | 3.34602249 |
| 50 | regulation of gamma-delta T cell activation (GO:0046643) | 3.34599177 |
| 51 | negative regulation of innate immune response (GO:0045824) | 3.24198446 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 3.23134779 |
| 53 | response to interleukin-15 (GO:0070672) | 3.22039184 |
| 54 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.20356222 |
| 55 | B cell mediated immunity (GO:0019724) | 3.19387646 |
| 56 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.19043922 |
| 57 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18458926 |
| 58 | cellular response to virus (GO:0098586) | 3.17700134 |
| 59 | regulation of activation of Janus kinase activity (GO:0010533) | 3.16227419 |
| 60 | leukocyte aggregation (GO:0070486) | 3.15654661 |
| 61 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14055769 |
| 62 | regulation of tolerance induction (GO:0002643) | 3.12732006 |
| 63 | DNA deamination (GO:0045006) | 3.12626262 |
| 64 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.10624905 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 3.07371423 |
| 66 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.05996141 |
| 67 | positive regulation of interferon-beta production (GO:0032728) | 3.04343452 |
| 68 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.04026182 |
| 69 | response to peptidoglycan (GO:0032494) | 3.03544715 |
| 70 | regulation of B cell differentiation (GO:0045577) | 3.02555474 |
| 71 | positive regulation of type 2 immune response (GO:0002830) | 3.01846772 |
| 72 | positive T cell selection (GO:0043368) | 2.99425376 |
| 73 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.98477716 |
| 74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.98338766 |
| 75 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.98338766 |
| 76 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.97761765 |
| 77 | cellular response to exogenous dsRNA (GO:0071360) | 2.97066729 |
| 78 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.95852232 |
| 79 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.95700286 |
| 80 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.93135265 |
| 81 | macrophage activation involved in immune response (GO:0002281) | 2.93050355 |
| 82 | lymphocyte chemotaxis (GO:0048247) | 2.92744875 |
| 83 | erythrocyte maturation (GO:0043249) | 2.91656274 |
| 84 | response to protozoan (GO:0001562) | 2.90177228 |
| 85 | NAD biosynthetic process (GO:0009435) | 2.89427800 |
| 86 | response to host immune response (GO:0052572) | 2.88775966 |
| 87 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.88775966 |
| 88 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.88581518 |
| 89 | positive regulation of tolerance induction (GO:0002645) | 2.88153399 |
| 90 | respiratory burst (GO:0045730) | 2.86340610 |
| 91 | detection of external biotic stimulus (GO:0098581) | 2.85592476 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84577410 |
| 93 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.83987297 |
| 94 | mast cell activation (GO:0045576) | 2.83053117 |
| 95 | regulation of antigen processing and presentation (GO:0002577) | 2.82300706 |
| 96 | myeloid cell activation involved in immune response (GO:0002275) | 2.81743577 |
| 97 | thymic T cell selection (GO:0045061) | 2.81369901 |
| 98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.81345286 |
| 99 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.79920964 |
| 100 | B cell receptor signaling pathway (GO:0050853) | 2.78912332 |
| 101 | negative regulation of T cell mediated immunity (GO:0002710) | 2.78300670 |
| 102 | cellular response to zinc ion (GO:0071294) | 2.78247755 |
| 103 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.77955617 |
| 104 | T cell selection (GO:0045058) | 2.77722860 |
| 105 | natural killer cell mediated immunity (GO:0002228) | 2.77107813 |
| 106 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.77107813 |
| 107 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.76857207 |
| 108 | regulation of chronic inflammatory response (GO:0002676) | 2.70951357 |
| 109 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70112015 |
| 110 | negative regulation of viral entry into host cell (GO:0046597) | 2.69653316 |
| 111 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.66782508 |
| 112 | dendritic cell differentiation (GO:0097028) | 2.65594641 |
| 113 | myeloid dendritic cell activation (GO:0001773) | 2.65120831 |
| 114 | regulation of natural killer cell differentiation (GO:0032823) | 2.64809272 |
| 115 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.64597779 |
| 116 | defense response to virus (GO:0051607) | 2.62829570 |
| 117 | NIK/NF-kappaB signaling (GO:0038061) | 2.60975328 |
| 118 | regulation of cholesterol esterification (GO:0010872) | 2.59869487 |
| 119 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.59264141 |
| 120 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.59264141 |
| 121 | phospholipid efflux (GO:0033700) | 2.58376742 |
| 122 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.56415222 |
| 123 | positive regulation of defense response to virus by host (GO:0002230) | 2.56180983 |
| 124 | myeloid dendritic cell differentiation (GO:0043011) | 2.55450562 |
| 125 | regulation of viral genome replication (GO:0045069) | 2.55135663 |
| 126 | neutrophil activation (GO:0042119) | 2.55036394 |
| 127 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.54877984 |
| 128 | regulation of defense response to virus by host (GO:0050691) | 2.54836441 |
| 129 | daunorubicin metabolic process (GO:0044597) | 2.54081121 |
| 130 | polyketide metabolic process (GO:0030638) | 2.54081121 |
| 131 | doxorubicin metabolic process (GO:0044598) | 2.54081121 |
| 132 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.53221532 |
| 133 | regulation of hypersensitivity (GO:0002883) | 2.52032338 |
| 134 | negative regulation of viral process (GO:0048525) | 2.51961176 |
| 135 | positive regulation of B cell differentiation (GO:0045579) | 2.51897725 |
| 136 | granulocyte activation (GO:0036230) | 2.51530862 |
| 137 | hemoglobin metabolic process (GO:0020027) | 2.50777051 |
| 138 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.50136333 |
| 139 | response to interferon-gamma (GO:0034341) | 2.48714581 |
| 140 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.46635273 |
| 141 | positive regulation of interleukin-12 production (GO:0032735) | 2.46109696 |
| 142 | indole-containing compound catabolic process (GO:0042436) | 2.46079357 |
| 143 | indolalkylamine catabolic process (GO:0046218) | 2.46079357 |
| 144 | tryptophan catabolic process (GO:0006569) | 2.46079357 |
| 145 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.45853439 |
| 146 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.45253981 |
| 147 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.44573755 |
| 148 | ribosomal small subunit assembly (GO:0000028) | 2.43781366 |
| 149 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.42737638 |
| 150 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.42652814 |
| 151 | aldehyde catabolic process (GO:0046185) | 2.41475289 |
| 152 | tetrapyrrole metabolic process (GO:0033013) | 2.40001488 |
| 153 | plasma lipoprotein particle assembly (GO:0034377) | 2.39787363 |
| 154 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.39583702 |
| 155 | cellular response to interferon-gamma (GO:0071346) | 2.38826133 |
| 156 | tryptophan metabolic process (GO:0006568) | 2.35976764 |
| 157 | positive regulation of T cell migration (GO:2000406) | 2.34270101 |
| 158 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.32492935 |
| 159 | response to thyroid hormone (GO:0097066) | 2.31334073 |
| 160 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.30758309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.82318726 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.55805380 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.22616099 |
| 4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.10391713 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.54577565 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.54032940 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.37423150 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.33708496 |
| 9 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.19849780 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.81174596 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.73287699 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67225623 |
| 13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57638539 |
| 14 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.40551395 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.39052761 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.36750497 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32609340 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29217912 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26740682 |
| 20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22270628 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21985547 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.19516482 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10567478 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07438342 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03768749 |
| 26 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.00087742 |
| 27 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99765088 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94023308 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.91350112 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82930937 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.81547000 |
| 32 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81283835 |
| 33 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.78495946 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75207957 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74676184 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69716964 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68370354 |
| 38 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.67599855 |
| 39 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65041401 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.62263534 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.62063357 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56291487 |
| 43 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.53065585 |
| 44 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.52044094 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50851663 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50635744 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48606414 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.47981167 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46789070 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45780544 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45095085 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44621840 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44339658 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43066966 |
| 55 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.40923856 |
| 56 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.40442763 |
| 57 | MYB_26560356_Chip-Seq_TH2_Human | 1.39046881 |
| 58 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.37531725 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35195621 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.34715525 |
| 61 | * MAF_26560356_Chip-Seq_TH1_Human | 1.34568078 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33641619 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.33282807 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.30240105 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29050794 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24091218 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21892292 |
| 68 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21670021 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20792276 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17021235 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14594722 |
| 72 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13128167 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.11394811 |
| 74 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.10930350 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10769626 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09829476 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09755149 |
| 78 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09194047 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07512231 |
| 80 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.07077299 |
| 81 | MYC_22102868_ChIP-Seq_BL_Human | 1.07072475 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.06298100 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04795965 |
| 84 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.03054130 |
| 85 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02068569 |
| 86 | P300_27268052_Chip-Seq_Bcells_Human | 1.01954392 |
| 87 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01166433 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01126218 |
| 89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00643244 |
| 90 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00364827 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00362453 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00289894 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99787978 |
| 94 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98606664 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97396626 |
| 96 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96940691 |
| 97 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.96222056 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95839746 |
| 99 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95529472 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94098025 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92054000 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 0.91860733 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91838515 |
| 104 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90949301 |
| 105 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90700502 |
| 106 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90183349 |
| 107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89501062 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88970327 |
| 109 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88900028 |
| 110 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88765040 |
| 111 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88606166 |
| 112 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.88241195 |
| 113 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.87967802 |
| 114 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.87816604 |
| 115 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87785150 |
| 116 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.87099604 |
| 117 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86436629 |
| 118 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.86225514 |
| 119 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.85803160 |
| 120 | SPI1_23127762_ChIP-Seq_K562_Human | 0.84691840 |
| 121 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.83652979 |
| 122 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.82969360 |
| 123 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.82028820 |
| 124 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.81326694 |
| 125 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81012631 |
| 126 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.80908621 |
| 127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80292982 |
| 128 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.79259484 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79082703 |
| 130 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79070871 |
| 131 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78478203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.14406931 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 3.74306767 |
| 3 | MP0009785_altered_susceptibility_to | 3.32361753 |
| 4 | MP0000685_abnormal_immune_system | 3.17404122 |
| 5 | MP0004147_increased_porphyrin_level | 2.96433769 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.72603283 |
| 7 | MP0003436_decreased_susceptibility_to | 2.69374655 |
| 8 | MP0005025_abnormal_response_to | 2.51671425 |
| 9 | MP0005671_abnormal_response_to | 2.46817090 |
| 10 | MP0001790_abnormal_immune_system | 2.39724506 |
| 11 | MP0005387_immune_system_phenotype | 2.39724506 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.36835302 |
| 13 | MP0003724_increased_susceptibility_to | 2.30288238 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.19788184 |
| 15 | MP0006082_CNS_inflammation | 2.17906111 |
| 16 | MP0005360_urolithiasis | 2.11777886 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.11063168 |
| 18 | MP0002419_abnormal_innate_immunity | 2.09847242 |
| 19 | MP0001800_abnormal_humoral_immune | 2.07878507 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.07074945 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 2.06198468 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.06198468 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.97299516 |
| 24 | MP0002723_abnormal_immune_serum | 1.96040560 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.94628791 |
| 26 | MP0003186_abnormal_redox_activity | 1.89983318 |
| 27 | MP0009840_abnormal_foam_cell | 1.86602783 |
| 28 | MP0005085_abnormal_gallbladder_physiolo | 1.84717301 |
| 29 | MP0001853_heart_inflammation | 1.82058540 |
| 30 | MP0009764_decreased_sensitivity_to | 1.81757949 |
| 31 | MP0003866_abnormal_defecation | 1.78798673 |
| 32 | MP0001819_abnormal_immune_cell | 1.76248797 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.74936328 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.73969348 |
| 35 | MP0008469_abnormal_protein_level | 1.73207903 |
| 36 | MP0002398_abnormal_bone_marrow | 1.71321474 |
| 37 | MP0005365_abnormal_bile_salt | 1.64111475 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.52297022 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.52240463 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.51707409 |
| 41 | MP0000716_abnormal_immune_system | 1.50807959 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49126923 |
| 43 | MP0002405_respiratory_system_inflammati | 1.46835126 |
| 44 | MP0004510_myositis | 1.46012050 |
| 45 | MP0002429_abnormal_blood_cell | 1.44086633 |
| 46 | MP0002006_tumorigenesis | 1.44053396 |
| 47 | MP0005083_abnormal_biliary_tract | 1.42380183 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.40908236 |
| 49 | MP0002722_abnormal_immune_system | 1.40431384 |
| 50 | MP0005310_abnormal_salivary_gland | 1.39642890 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.37031813 |
| 52 | MP0003011_delayed_dark_adaptation | 1.36206459 |
| 53 | MP0001348_abnormal_lacrimal_gland | 1.34952191 |
| 54 | MP0009697_abnormal_copulation | 1.29701926 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 1.28135141 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.27774869 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.27451212 |
| 58 | MP0004947_skin_inflammation | 1.26337025 |
| 59 | MP0000490_abnormal_crypts_of | 1.25052183 |
| 60 | MP0002132_abnormal_respiratory_system | 1.24061889 |
| 61 | MP0009763_increased_sensitivity_to | 1.23459228 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.22951597 |
| 63 | MP0002254_reproductive_system_inflammat | 1.19248613 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 1.16922711 |
| 65 | MP0000609_abnormal_liver_physiology | 1.16650300 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.16388628 |
| 67 | MP0003252_abnormal_bile_duct | 1.14920476 |
| 68 | MP0010329_abnormal_lipoprotein_level | 1.13580282 |
| 69 | MP0000343_altered_response_to | 1.12194880 |
| 70 | MP0000604_amyloidosis | 1.11726977 |
| 71 | MP0003763_abnormal_thymus_physiology | 1.10640520 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.10523463 |
| 73 | MP0005166_decreased_susceptibility_to | 1.10422454 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 1.10091160 |
| 75 | MP0009278_abnormal_bone_marrow | 1.09790401 |
| 76 | MP0001764_abnormal_homeostasis | 1.08538448 |
| 77 | MP0003195_calcinosis | 1.05700860 |
| 78 | MP0001873_stomach_inflammation | 1.04234674 |
| 79 | MP0005174_abnormal_tail_pigmentation | 1.03426222 |
| 80 | MP0002933_joint_inflammation | 0.98799711 |
| 81 | MP0002163_abnormal_gland_morphology | 0.97166241 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.96526878 |
| 83 | MP0000598_abnormal_liver_morphology | 0.94465995 |
| 84 | MP0001663_abnormal_digestive_system | 0.93980769 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.92923256 |
| 86 | MP0010307_abnormal_tumor_latency | 0.91860876 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90776346 |
| 88 | MP0000858_altered_metastatic_potential | 0.90223840 |
| 89 | MP0002277_abnormal_respiratory_mucosa | 0.89357910 |
| 90 | MP0003448_altered_tumor_morphology | 0.88884493 |
| 91 | MP0008260_abnormal_autophagy | 0.87636627 |
| 92 | MP0004883_abnormal_blood_vessel | 0.86464900 |
| 93 | MP0008057_abnormal_DNA_replication | 0.85613828 |
| 94 | MP0005390_skeleton_phenotype | 0.83184942 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.82686681 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 0.79573736 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.79486676 |
| 98 | MP0003303_peritoneal_inflammation | 0.77447732 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.76892423 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.75306630 |
| 101 | MP0003075_altered_response_to | 0.74002912 |
| 102 | MP0004019_abnormal_vitamin_homeostasis | 0.73510272 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.73274920 |
| 104 | MP0005164_abnormal_response_to | 0.72886950 |
| 105 | MP0000703_abnormal_thymus_morphology | 0.70939586 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.70222547 |
| 107 | MP0002095_abnormal_skin_pigmentation | 0.69722064 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.69425346 |
| 109 | MP0001542_abnormal_bone_strength | 0.65248015 |
| 110 | MP0005332_abnormal_amino_acid | 0.64742585 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 0.64237333 |
| 112 | MP0001905_abnormal_dopamine_level | 0.63373719 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.63159445 |
| 114 | MP0003690_abnormal_glial_cell | 0.62413951 |
| 115 | MP0003943_abnormal_hepatobiliary_system | 0.62364248 |
| 116 | MP0005451_abnormal_body_composition | 0.61132317 |
| 117 | MP0003300_gastrointestinal_ulcer | 0.60419468 |
| 118 | MP0003787_abnormal_imprinting | 0.59001860 |
| 119 | MP0008004_abnormal_stomach_pH | 0.56759188 |
| 120 | MP0008874_decreased_physiological_sensi | 0.56088488 |
| 121 | MP0001851_eye_inflammation | 0.55979906 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.54147690 |
| 123 | MP0008873_increased_physiological_sensi | 0.54005225 |
| 124 | MP0003795_abnormal_bone_structure | 0.53135307 |
| 125 | MP0000249_abnormal_blood_vessel | 0.51996535 |
| 126 | MP0003045_fibrosis | 0.51640640 |
| 127 | MP0005535_abnormal_body_temperature | 0.50687264 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.50586311 |
| 129 | MP0005381_digestive/alimentary_phenotyp | 0.49765029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.14174419 |
| 2 | Poikilocytosis (HP:0004447) | 4.60270092 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 4.55306068 |
| 4 | Stomatitis (HP:0010280) | 4.52490442 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.41390972 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.08965782 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.87002178 |
| 8 | T lymphocytopenia (HP:0005403) | 3.83794938 |
| 9 | Abnormality of T cell number (HP:0011839) | 3.76920426 |
| 10 | Hypochromic anemia (HP:0001931) | 3.73629579 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.71929631 |
| 12 | Increased IgM level (HP:0003496) | 3.68713685 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.67207248 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.65552623 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.56711980 |
| 16 | Obstructive lung disease (HP:0006536) | 3.55243108 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.55243108 |
| 18 | Petechiae (HP:0000967) | 3.40775113 |
| 19 | Microcytic anemia (HP:0001935) | 3.38442422 |
| 20 | Acanthocytosis (HP:0001927) | 3.34390582 |
| 21 | Agammaglobulinemia (HP:0004432) | 3.28938158 |
| 22 | Myositis (HP:0100614) | 3.25601256 |
| 23 | Gingival bleeding (HP:0000225) | 3.17576536 |
| 24 | Joint hemorrhage (HP:0005261) | 3.13050433 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.08063884 |
| 26 | Chronic otitis media (HP:0000389) | 3.06726590 |
| 27 | Abnormality of B cell number (HP:0010975) | 3.04263692 |
| 28 | Severe combined immunodeficiency (HP:0004430) | 2.97647433 |
| 29 | Leukocytosis (HP:0001974) | 2.95505488 |
| 30 | Epistaxis (HP:0000421) | 2.94988519 |
| 31 | Hemoptysis (HP:0002105) | 2.94579899 |
| 32 | Abnormality of macrophages (HP:0004311) | 2.93656398 |
| 33 | Urticaria (HP:0001025) | 2.92501486 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 2.91254564 |
| 35 | Hyperbilirubinemia (HP:0002904) | 2.89391703 |
| 36 | Purpura (HP:0000979) | 2.88241616 |
| 37 | Thrombocytosis (HP:0001894) | 2.87768313 |
| 38 | Orchitis (HP:0100796) | 2.86605373 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 2.85775266 |
| 40 | Recurrent skin infections (HP:0001581) | 2.84166258 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.81679645 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.80136659 |
| 43 | Granulocytopenia (HP:0001913) | 2.78570619 |
| 44 | Eosinophilia (HP:0001880) | 2.75816546 |
| 45 | Vasculitis (HP:0002633) | 2.75799399 |
| 46 | B lymphocytopenia (HP:0010976) | 2.75104187 |
| 47 | Abnormality of the nasal mucosa (HP:0000433) | 2.74986942 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.74563041 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.72398006 |
| 50 | Reticulocytosis (HP:0001923) | 2.72353803 |
| 51 | Nasal polyposis (HP:0100582) | 2.71772869 |
| 52 | Nausea (HP:0002018) | 2.67902122 |
| 53 | Increased IgE level (HP:0003212) | 2.65132960 |
| 54 | Recurrent viral infections (HP:0004429) | 2.65088139 |
| 55 | Increased serum ferritin (HP:0003281) | 2.64893859 |
| 56 | Chest pain (HP:0100749) | 2.60580647 |
| 57 | Reduced antithrombin III activity (HP:0001976) | 2.58740161 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.58350046 |
| 59 | Tetraparesis (HP:0002273) | 2.56916523 |
| 60 | Cholelithiasis (HP:0001081) | 2.54746102 |
| 61 | Polycythemia (HP:0001901) | 2.54588400 |
| 62 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.53403039 |
| 63 | Mediastinal lymphadenopathy (HP:0100721) | 2.53053337 |
| 64 | Abnormality of eosinophils (HP:0001879) | 2.52977625 |
| 65 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.52103722 |
| 66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.52103722 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.52103722 |
| 68 | Optic neuritis (HP:0100653) | 2.49339092 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 2.49339092 |
| 70 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.48808954 |
| 71 | Gangrene (HP:0100758) | 2.48376523 |
| 72 | Lymphopenia (HP:0001888) | 2.48354636 |
| 73 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.47561603 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.46741628 |
| 75 | Pustule (HP:0200039) | 2.46412615 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.45334884 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.45246022 |
| 78 | Combined immunodeficiency (HP:0005387) | 2.44188262 |
| 79 | Vacuolated lymphocytes (HP:0001922) | 2.42645411 |
| 80 | Abnormal gallbladder morphology (HP:0012437) | 2.38953362 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.38053755 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.37650172 |
| 83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.35987930 |
| 84 | Recurrent cutaneous fungal infections (HP:0011370) | 2.35987930 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35959902 |
| 86 | Chronic diarrhea (HP:0002028) | 2.33508729 |
| 87 | Basal ganglia calcification (HP:0002135) | 2.33392674 |
| 88 | Anorexia (HP:0002039) | 2.33349876 |
| 89 | Gastrointestinal infarctions (HP:0005244) | 2.31454242 |
| 90 | Pulmonary embolism (HP:0002204) | 2.29950586 |
| 91 | Abnormality of reticulocytes (HP:0004312) | 2.27855840 |
| 92 | Inflammation of the large intestine (HP:0002037) | 2.26675390 |
| 93 | Cutaneous photosensitivity (HP:0000992) | 2.24250906 |
| 94 | Skin rash (HP:0000988) | 2.24172586 |
| 95 | Intrahepatic cholestasis (HP:0001406) | 2.19976632 |
| 96 | Thrombophlebitis (HP:0004418) | 2.19367735 |
| 97 | Spontaneous abortion (HP:0005268) | 2.19018383 |
| 98 | Recurrent sinusitis (HP:0011108) | 2.17302181 |
| 99 | Hypobetalipoproteinemia (HP:0003563) | 2.17122325 |
| 100 | Thyroiditis (HP:0100646) | 2.17060665 |
| 101 | Gastrointestinal inflammation (HP:0004386) | 2.17005296 |
| 102 | Acute hepatic failure (HP:0006554) | 2.16746754 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.16262708 |
| 104 | Deep venous thrombosis (HP:0002625) | 2.15957317 |
| 105 | Abnormal number of erythroid precursors (HP:0012131) | 2.15547902 |
| 106 | Paralysis (HP:0003470) | 2.12959073 |
| 107 | Arterial thrombosis (HP:0004420) | 2.12125555 |
| 108 | Abnormal platelet function (HP:0011869) | 2.11458373 |
| 109 | Impaired platelet aggregation (HP:0003540) | 2.11458373 |
| 110 | Episodic fever (HP:0001954) | 2.10095683 |
| 111 | Joint swelling (HP:0001386) | 2.08479140 |
| 112 | Abnormality of the common coagulation pathway (HP:0010990) | 2.08440798 |
| 113 | Recurrent bronchitis (HP:0002837) | 2.08165734 |
| 114 | Hypoproteinemia (HP:0003075) | 2.07769544 |
| 115 | Gingivitis (HP:0000230) | 2.06564395 |
| 116 | Complement deficiency (HP:0004431) | 2.05823843 |
| 117 | Sepsis (HP:0100806) | 2.04928468 |
| 118 | Chronic sinusitis (HP:0011109) | 2.04725764 |
| 119 | Meningitis (HP:0001287) | 2.04519120 |
| 120 | Vertebral compression fractures (HP:0002953) | 2.04198537 |
| 121 | Periodontitis (HP:0000704) | 2.03690105 |
| 122 | IgM deficiency (HP:0002850) | 2.03594122 |
| 123 | Abnormality of T cells (HP:0002843) | 2.02222181 |
| 124 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.01462471 |
| 125 | Osteomalacia (HP:0002749) | 2.00554418 |
| 126 | Myocardial infarction (HP:0001658) | 1.99633386 |
| 127 | Abnormality of the prostate (HP:0008775) | 1.98905754 |
| 128 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.98439405 |
| 129 | Xanthomatosis (HP:0000991) | 1.98285422 |
| 130 | Hepatocellular necrosis (HP:0001404) | 1.96076690 |
| 131 | Aplastic anemia (HP:0001915) | 1.95582854 |
| 132 | Hypertensive crisis (HP:0100735) | 1.94915960 |
| 133 | Encephalitis (HP:0002383) | 1.94744636 |
| 134 | Mitochondrial inheritance (HP:0001427) | 1.94187267 |
| 135 | Pulmonary infiltrates (HP:0002113) | 1.94054319 |
| 136 | Cellulitis (HP:0100658) | 1.93866488 |
| 137 | Poor head control (HP:0002421) | 1.93696503 |
| 138 | Hepatocellular carcinoma (HP:0001402) | 1.92996227 |
| 139 | Amaurosis fugax (HP:0100576) | 1.92160046 |
| 140 | Lower limb hyperreflexia (HP:0002395) | 1.92093114 |
| 141 | Stomach cancer (HP:0012126) | 1.91439728 |
| 142 | IgG deficiency (HP:0004315) | 1.89565148 |
| 143 | Premature loss of primary teeth (HP:0006323) | 1.88895066 |
| 144 | Interstitial pulmonary disease (HP:0006530) | 1.88747092 |
| 145 | Menorrhagia (HP:0000132) | 1.88701031 |
| 146 | Glomerulonephritis (HP:0000099) | 1.88176834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 3.62083156 |
| 2 | MAP3K14 | 3.36529866 |
| 3 | IRAK4 | 3.33685625 |
| 4 | TBK1 | 3.24429087 |
| 5 | TYK2 | 3.04706446 |
| 6 | IKBKE | 3.03735719 |
| 7 | KIT | 2.87946993 |
| 8 | NME2 | 2.61389219 |
| 9 | FES | 2.50931164 |
| 10 | IKBKB | 2.46095668 |
| 11 | EIF2AK1 | 2.44145720 |
| 12 | JAK3 | 2.33991327 |
| 13 | PIM2 | 2.23045774 |
| 14 | IRAK3 | 2.13886135 |
| 15 | TNK2 | 2.07275598 |
| 16 | MAP4K1 | 2.04943370 |
| 17 | FLT3 | 1.97597985 |
| 18 | FGFR4 | 1.80807857 |
| 19 | ERN1 | 1.68003422 |
| 20 | VRK2 | 1.66558722 |
| 21 | CHUK | 1.65455628 |
| 22 | PIM1 | 1.65406098 |
| 23 | BLK | 1.64509166 |
| 24 | PBK | 1.63905728 |
| 25 | STK4 | 1.62105556 |
| 26 | TXK | 1.61378590 |
| 27 | ITK | 1.60107455 |
| 28 | TGFBR2 | 1.57917866 |
| 29 | TLK1 | 1.53019216 |
| 30 | TAOK3 | 1.50412557 |
| 31 | SYK | 1.49244932 |
| 32 | CSF1R | 1.46981925 |
| 33 | ZAK | 1.39425653 |
| 34 | MATK | 1.38750067 |
| 35 | JAK1 | 1.38023290 |
| 36 | TIE1 | 1.35793042 |
| 37 | TESK1 | 1.35453511 |
| 38 | ZAP70 | 1.32247048 |
| 39 | TEC | 1.30388480 |
| 40 | ADRBK2 | 1.29725255 |
| 41 | NEK9 | 1.25713957 |
| 42 | MAP2K3 | 1.24193314 |
| 43 | STK16 | 1.15815341 |
| 44 | EIF2AK2 | 1.15211243 |
| 45 | BTK | 1.13689188 |
| 46 | BCKDK | 1.13514899 |
| 47 | MAP3K13 | 1.11187459 |
| 48 | MAP4K2 | 1.08882450 |
| 49 | VRK1 | 1.08447329 |
| 50 | LYN | 1.06748447 |
| 51 | PRKCQ | 1.05476167 |
| 52 | CDK19 | 1.04876097 |
| 53 | RPS6KA4 | 1.02287039 |
| 54 | FGR | 1.00263612 |
| 55 | MAPK11 | 0.98875759 |
| 56 | RPS6KA5 | 0.98821628 |
| 57 | RIPK4 | 0.92265692 |
| 58 | LIMK1 | 0.91356412 |
| 59 | PIK3CG | 0.90052575 |
| 60 | SIK3 | 0.89457016 |
| 61 | MST4 | 0.85659220 |
| 62 | DYRK3 | 0.82827602 |
| 63 | NUAK1 | 0.82768838 |
| 64 | EPHB1 | 0.82440842 |
| 65 | FGFR3 | 0.81454548 |
| 66 | CSK | 0.81335056 |
| 67 | CDK12 | 0.81104698 |
| 68 | LCK | 0.80968806 |
| 69 | JAK2 | 0.80336231 |
| 70 | MAP3K11 | 0.79662681 |
| 71 | PRPF4B | 0.79662058 |
| 72 | ABL2 | 0.79486139 |
| 73 | GRK6 | 0.74699947 |
| 74 | STK10 | 0.73595491 |
| 75 | ACVR1B | 0.73326922 |
| 76 | DAPK1 | 0.71282672 |
| 77 | EPHA3 | 0.71166400 |
| 78 | TRPM7 | 0.70062811 |
| 79 | BRSK2 | 0.69858798 |
| 80 | KDR | 0.67859518 |
| 81 | NLK | 0.66123058 |
| 82 | CDK6 | 0.66002698 |
| 83 | YES1 | 0.65980885 |
| 84 | HCK | 0.64854333 |
| 85 | TAOK1 | 0.64574451 |
| 86 | FYN | 0.62985660 |
| 87 | MARK3 | 0.62154807 |
| 88 | GRK5 | 0.61856341 |
| 89 | BMPR2 | 0.60667316 |
| 90 | WEE1 | 0.60407269 |
| 91 | DYRK1B | 0.59230108 |
| 92 | IRAK1 | 0.58595733 |
| 93 | GRK7 | 0.58018784 |
| 94 | PRKCD | 0.57806316 |
| 95 | MAP3K5 | 0.57441823 |
| 96 | RPS6KA6 | 0.54373278 |
| 97 | DYRK2 | 0.53852624 |
| 98 | HIPK2 | 0.52570938 |
| 99 | MAPKAPK2 | 0.51743012 |
| 100 | TGFBR1 | 0.49687036 |
| 101 | CDK4 | 0.48932560 |
| 102 | LRRK2 | 0.47164970 |
| 103 | BRD4 | 0.47144724 |
| 104 | MAP2K6 | 0.46884431 |
| 105 | MAP3K12 | 0.45509578 |
| 106 | TAOK2 | 0.43985456 |
| 107 | ATR | 0.42543914 |
| 108 | MYLK | 0.39439486 |
| 109 | SIK2 | 0.38843054 |
| 110 | GRK1 | 0.37588295 |
| 111 | MAP3K8 | 0.36318186 |
| 112 | PLK4 | 0.35653830 |
| 113 | MAPKAPK3 | 0.35250831 |
| 114 | CLK1 | 0.34725306 |
| 115 | MKNK1 | 0.33754450 |
| 116 | ABL1 | 0.33204406 |
| 117 | AURKB | 0.32899586 |
| 118 | PRKAA2 | 0.32647837 |
| 119 | BMPR1B | 0.32354021 |
| 120 | PINK1 | 0.31287913 |
| 121 | CSNK2A1 | 0.29824129 |
| 122 | PRKG2 | 0.29504601 |
| 123 | MAP3K3 | 0.29305177 |
| 124 | MAP3K1 | 0.28706313 |
| 125 | CDK7 | 0.27981849 |
| 126 | MOS | 0.27967113 |
| 127 | RPS6KC1 | 0.27774322 |
| 128 | DAPK2 | 0.27401205 |
| 129 | IRAK2 | 0.27141374 |
| 130 | IGF1R | 0.24629674 |
| 131 | PDK1 | 0.23882301 |
| 132 | CDC42BPA | 0.23642563 |
| 133 | MAPK4 | 0.22854785 |
| 134 | INSR | 0.22669793 |
| 135 | MAPK7 | 0.22501624 |
| 136 | DAPK3 | 0.21583119 |
| 137 | ADRBK1 | 0.21522806 |
| 138 | MAPK3 | 0.20835704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.09333968 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.79716387 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.75691066 |
| 4 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.33588332 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.31304252 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.22560433 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.22250083 |
| 8 | Viral myocarditis_Homo sapiens_hsa05416 | 2.14662326 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.13754772 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.05682767 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02133552 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94882864 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.91036919 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83589804 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.82190952 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79310335 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.74647993 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68123145 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.62543786 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.61032657 |
| 21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.57332868 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.57150727 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.49627606 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.47859139 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.41422774 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.38182552 |
| 27 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.37970556 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37966940 |
| 29 | Ribosome_Homo sapiens_hsa03010 | 1.36469635 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33775092 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.32954396 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31033381 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29590012 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.29083600 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.28260039 |
| 36 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.27949295 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27083812 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25122252 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24134301 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.22369306 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.21739989 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20368440 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14805359 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14326808 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.10824364 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09381127 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.06828618 |
| 48 | Base excision repair_Homo sapiens_hsa03410 | 1.04424876 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.04312854 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04129995 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01288946 |
| 52 | Mismatch repair_Homo sapiens_hsa03430 | 1.00898251 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99414752 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99238598 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98990121 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98485506 |
| 57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.98046419 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.97797281 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93043173 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91510598 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90333905 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89582173 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.87355687 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86092316 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85710626 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85586038 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83949048 |
| 68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82951345 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.82345692 |
| 70 | Homologous recombination_Homo sapiens_hsa03440 | 0.82122442 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80749858 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.80669693 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78827332 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78671354 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.77477046 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74510993 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74448407 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74195935 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73762595 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.73056903 |
| 81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72359437 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72232343 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71870058 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70455756 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69036130 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68110596 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61734988 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58992256 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58197279 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.57404412 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57360163 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56729765 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56482750 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53643318 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53548797 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52991146 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52853264 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52615950 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52302704 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51511738 |
| 101 | Lysosome_Homo sapiens_hsa04142 | 0.51349400 |
| 102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50797770 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50437392 |
| 104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50095117 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49942650 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49902489 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49477875 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48069501 |
| 109 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46733034 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45783513 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45589991 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43822132 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42955848 |
| 114 | RNA polymerase_Homo sapiens_hsa03020 | 0.42839554 |
| 115 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.41835527 |
| 116 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41557615 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41423635 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41376280 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39800714 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.39031759 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36328399 |
| 122 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35367052 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32237238 |
| 124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.29463650 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.27770190 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26823547 |
| 127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.22621728 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.11607910 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.05808404 |
| 130 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.05138508 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.03891173 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.03825398 |
| 133 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.03005787 |
| 134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.00527400 |

